Pyrophosphate as a biomarker for artery hardening in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at a substance in the blood called pyrophosphate that may help doctors detect a type of artery hardening (mediacalcinosis) in people with type 2 diabetes. It tests whether this substance can be a useful early warning sign.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 40 and 70 years old.
- You have type 2 diabetes that has lasted at least 6 months.
- You take a medication called an SGLT2 inhibitor (like canagliflozin, dapagliflozin, or empagliflozin).
- You do not have advanced kidney disease (stage 3 or worse).
- You live in the Alpes-Maritimes or Var area of France.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This study looks at how platelets (the cells that help blood clot) may be affected in people with type 2 diabetes. It aims to understand if diabetes changes platelet function, which could help improve heart health in the future.
This early study looks at how “autophagy” (your body’s cell recycling process) relates to small blood-vessel problems in people with type 2 diabetes. It may help researchers understand mechanisms and possible future treatments, mainly for people who meet specific health and medication criteria.
This study looks at how the liver uses energy (mitochondria) in people with type 2 diabetes and fatty liver disease. By understanding this, researchers may find better ways to treat liver problems.
This study looks at a natural chemical in the body called pyrophosphate (PPi) in children with chronic kidney disease. It aims to understand how kidney problems affect this chemical, which is important for bone health. The study needs kids with different kidney stages, including those on dialysis, with a transplant, or even healthy kids having surgery for comparison.
This study tests a simple, noninvasive technique (photoplethysmography) to measure blood flow in the legs of people with type 2 diabetes. It may help doctors better detect and monitor peripheral artery disease (PAD), a condition that narrows arteries and can lead to leg pain or poor healing.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.